Clinical Trial Update: Seal, Stopping Eczema and Allergy Study [Phase 2]

View source ↗

Summary

Phase 2 eczema and allergy trial is being stopped. The current status is ACTIVE_NOT_RECRUITING, indicating no recruitment at this time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Infantile Atopic Dermatitis

Snippet

Sponsor: Kari Nadeau, MD, PhD | Conditions: Eczema, Infantile, Eczema | Phase 2 | Status: ACTIVE_NOT_RECRUITING